- ►shouxi.net J Janke, S Engeli, M Boschmann, F Adams, J … - Diabetes, 2006 - Am Diabetes Assoc Studies in mice suggest that adipocytes serve as glucose sensors and regulate
systemic glucose metabolism through release of serum retinol-binding protein 4
(RBP4). This model has not been validated in humans. RBP4 was highly ... Cited by 145 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org M Blüher, S Engeli, N Klöting, J Berndt, M … - Diabetes, 2006 - Am Diabetes Assoc The endocannabinoid system has been suspected to contribute to the association
of visceral fat accumulation with metabolic diseases. We determined whether
circulating endocannabinoids are related to visceral adipose tissue mass in ... Cited by 131 - Related articles - BL Direct - All 8 versions
- ►jimmunol.org AR Moschen, A Kaser, B Enrich, B Mosheimer, … - The Journal of Immunology, 2007 - Am Assoc Immnol Adipocytokines are mainly adipocyte-derived cytokines regulating metabolism and
as such are key regulators of insulin resistance. Some adipocytokines such as
adiponectin and leptin affect immune and inflammatory functions. Visfatin ... Cited by 122 - Related articles - BL Direct - All 5 versions
- ►endojournals.org C Pagano, C Pilon, M Olivieri, P Mason, R … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Results: Plasma visfatin and its mRNA in SAT were significantly lower in obese
subjects, compared with normal-weight controls. Both circulating visfatin and
SAT visfatin mRNA were negatively correlated with body mass index, whereas ... Cited by 115 - Related articles - BL Direct - All 6 versions
DG Haider, G Schaller, S Kapiotis, C Maier, A … - Diabetologia, 2006 - Springer Abstract Aims/hypothesis The novel insulin-mimetic adipocytokine visfatin has
been linked to the metabolic syndrome, but its regulation has not been
characterised to date. Since insulin- mimetic actions of visfatin may be ... Cited by 105 - Related articles - BL Direct - All 4 versions
- ►endojournals.org A Hammarstedt, J Pihlajamaki, V Rotter … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Objective: The objective of this study was to examine whether visfatin is a true
adipokine and is expressed in isolated fat cells. We also examined whether
visfatin is regulated by thiazolidinediones and, thus, can contribute to ... Cited by 98 - Related articles - BL Direct - All 4 versions
K Krzyzanowska, W Krugluger, F Mittermayer … - Clinical Science, 2006 - clinsci.org The recently discovered adipocytokine visfatin has insulin-like properties. It
lowers blood glucose and improves insulin sensitivity; however, clinical data on
visfatin are limited. To evaluate the role of visfatin in GDM (gestational ... Cited by 91 - Related articles - Cached - BL Direct - All 10 versions
- ►nih.gov [PDF] JR Revollo, A Körner, KF Mills, A Satoh, T … - Cell metabolism, 2007 - Elsevier Intracellular nicotinamide phosphoribosyltransferase (iNampt) is an essential
enzyme in the NAD biosynthetic pathway. An extracellular form of this protein
(eNampt) has been reported to act as a cytokine named PBEF or an ... Cited by 90 - Related articles - All 7 versions
- ►diabetesjournals.org A Lopez-Bermejo, B Chico-Julia, M Fernandez … - Diabetes, 2006 - Am Diabetes Assoc Visfatin has shown to be increased in type 2 diabetes but to be unrelated to
insulin sensitivity. We hypothesized that visfatin is associated with insulin
secretion in humans. To this aim, a cross-sectional study was conducted in ... Cited by 82 - Related articles - BL Direct - All 5 versions
